Determinants of effective treatment coverage for posttraumatic stress disorder
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/152215 |
Resumo: | Funding Information: The Argentina survey − Estudio Argentino de Epidemiología en Salud Mental (EASM) − was supported by a grant from the Argentinian Ministry of Health (Ministerio de Salud de la Nación) − (Grant Number 2002–17270/13–5). The São Paulo Megacity Mental Health Survey is supported by the State of São Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204–3. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The Mental Health Study Medellín – Colombia was carried out and supported jointly by the Center for Excellence on Research in Mental Health (CES University) and the Secretary of Health of Medellín. The ESEMeD project is funded by the European Commission (Contracts QLG5–1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region (Italy)), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000–158-CE), Generalitat de Catalunya (2017 SGR 452; 2014 SGR 748), Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Lebanese Evaluation of the Burden of Ailments and Needs of the Nation (L.E.B.A.N.O.N.) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health / Fogarty International Center (R03 TW006481–01), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from, Algorithm, AstraZeneca, Benta, Bella Pharma, Eli Lilly, Glaxo Smith Kline, Lundbeck, Novartis, OmniPharma, Pfizer, Phenicia, Servier, UPO. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544- H), with supplemental support from the Pan American Health Organization (PAHO). The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and Ministry of Health. The Romania WMH study projects “Policies in Mental Health Area” and “National Study regarding Mental Health and Services Use” were carried out by National School of Public Health & Health Services Management (former National Institute for Research & Development in Health), with technical support of Metro Media Transilvania, the National Institute of Statistics-National Centre for Training in Statistics, SC Cheyenne Services SRL, Statistics Netherlands and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL. The Psychiatric Enquiry to General Population in Southeast Spain – Murcia (PEGASUS-Murcia) Project has been financed by the Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejería de Sanidad y Política Social) and Fundación para la Formación e Investigación Sanitarias (FFIS) of Murcia. The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. Dr. Stein is supported by the Medical Research Council of South Africa (MRC). Publisher Copyright: © 2023, The Author(s). |
id |
RCAP_7a3e320c401210291f9d8a1ef1f01811 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/152215 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Determinants of effective treatment coverage for posttraumatic stress disorderfindings from the World Mental Health SurveysContact coverageEffective treatment coverageInsurancePosttraumatic stress disorderPsychiatry and Mental healthSDG 3 - Good Health and Well-beingFunding Information: The Argentina survey − Estudio Argentino de Epidemiología en Salud Mental (EASM) − was supported by a grant from the Argentinian Ministry of Health (Ministerio de Salud de la Nación) − (Grant Number 2002–17270/13–5). The São Paulo Megacity Mental Health Survey is supported by the State of São Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204–3. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The Mental Health Study Medellín – Colombia was carried out and supported jointly by the Center for Excellence on Research in Mental Health (CES University) and the Secretary of Health of Medellín. The ESEMeD project is funded by the European Commission (Contracts QLG5–1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region (Italy)), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000–158-CE), Generalitat de Catalunya (2017 SGR 452; 2014 SGR 748), Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Lebanese Evaluation of the Burden of Ailments and Needs of the Nation (L.E.B.A.N.O.N.) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health / Fogarty International Center (R03 TW006481–01), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from, Algorithm, AstraZeneca, Benta, Bella Pharma, Eli Lilly, Glaxo Smith Kline, Lundbeck, Novartis, OmniPharma, Pfizer, Phenicia, Servier, UPO. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544- H), with supplemental support from the Pan American Health Organization (PAHO). The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and Ministry of Health. The Romania WMH study projects “Policies in Mental Health Area” and “National Study regarding Mental Health and Services Use” were carried out by National School of Public Health & Health Services Management (former National Institute for Research & Development in Health), with technical support of Metro Media Transilvania, the National Institute of Statistics-National Centre for Training in Statistics, SC Cheyenne Services SRL, Statistics Netherlands and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL. The Psychiatric Enquiry to General Population in Southeast Spain – Murcia (PEGASUS-Murcia) Project has been financed by the Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejería de Sanidad y Política Social) and Fundación para la Formación e Investigación Sanitarias (FFIS) of Murcia. The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. Dr. Stein is supported by the Medical Research Council of South Africa (MRC). Publisher Copyright: © 2023, The Author(s).Background: Posttraumatic stress disorder (PTSD) is associated with significant morbidity, but efficacious pharmacotherapy and psychotherapy are available. Data from the World Mental Health Surveys were used to investigate extent and predictors of treatment coverage for PTSD in high-income countries (HICs) as well as in low- and middle-income countries (LMICs). Methods: Seventeen surveys were conducted across 15 countries (9 HICs, 6 LMICs) by the World Health Organization (WHO) World Mental Health Surveys. Of 35,012 respondents, 914 met DSM-IV criteria for 12-month PTSD. Components of treatment coverage analyzed were: (a) any mental health service utilization; (b) adequate pharmacotherapy; (c) adequate psychotherapy; and (d) effective treatment coverage. Regression models investigated predictors of treatment coverage. Results: 12-month PTSD prevalence in trauma exposed individuals was 1.49 (S.E., 0.08). A total of 43.0% (S.E., 2.2) received any mental health services, with fewer receiving adequate pharmacotherapy (13.5%), adequate psychotherapy (17.2%), or effective treatment coverage (14.4%), and with all components of treatment coverage lower in LMICs than HICs. In a multivariable model having insurance (OR = 2.31, 95 CI 1.17, 4.57) and severity of symptoms (OR =.35, 95% CI 0.18, 0.70) were predictive of effective treatment coverage. Conclusion: There is a clear need to improve pharmacotherapy and psychotherapy coverage for PTSD, particularly in those with mild symptoms, and especially in LMICs. Universal health care insurance can be expected to increase effective treatment coverage and therefore improve outcomes.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)Comprehensive Health Research Centre (CHRC) - pólo NMSRUNStein, Dan J.Kazdin, Alan E.Munthali, Richard J.Hwang, IrvingHarris, Meredith G.Alonso, JordiAndrade, Laura HelenaBruffaerts, RonnyCardoso, GraçaChardoul, Stephaniede Girolamo, GiovanniFlorescu, SilviaGureje, OyeHaro, Josep MariaKaram, Aimee NasserKaram, Elie G.Kovess-Masfety, VivianeLee, SingMedina-Mora, Maria ElenaNavarro-Mateu, FernandoPosada-Villa, JoséStagnaro, Juan Carlosten Have, MargreetSampson, Nancy A.Kessler, Ronald C.Vigo, Daniel V.Aguilar-Gaxiola, SergioAl-Hamzawi, AliAltwaijri, Yasmin A.Atwoli, LukoyeBenjet, CorinaBorges, GuilhermeBromet, Evelyn J.Bunting, BrendanCaldas-de-Almeida, Jose MiguelChatterji, SomnathCia, Alfredo H.Degenhardt, LouisaDemyttenaere, KoenHinkov, HristoHu, Chi yide Jonge, PeterKaram, Aimee NasserKaram, GeorgesKawakami, NoritoKiejna, AndrzejLepine, Jean PierreMcGrath, John J.Moskalewicz, JacekPiazza, Marina2023-04-27T22:19:12Z2023-042023-04-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10362/152215eng1471-244XPURE: 59473424https://doi.org/10.1186/s12888-023-04605-2info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-05-22T18:11:06Zoai:run.unl.pt:10362/152215Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-05-22T18:11:06Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Determinants of effective treatment coverage for posttraumatic stress disorder findings from the World Mental Health Surveys |
title |
Determinants of effective treatment coverage for posttraumatic stress disorder |
spellingShingle |
Determinants of effective treatment coverage for posttraumatic stress disorder Stein, Dan J. Contact coverage Effective treatment coverage Insurance Posttraumatic stress disorder Psychiatry and Mental health SDG 3 - Good Health and Well-being |
title_short |
Determinants of effective treatment coverage for posttraumatic stress disorder |
title_full |
Determinants of effective treatment coverage for posttraumatic stress disorder |
title_fullStr |
Determinants of effective treatment coverage for posttraumatic stress disorder |
title_full_unstemmed |
Determinants of effective treatment coverage for posttraumatic stress disorder |
title_sort |
Determinants of effective treatment coverage for posttraumatic stress disorder |
author |
Stein, Dan J. |
author_facet |
Stein, Dan J. Kazdin, Alan E. Munthali, Richard J. Hwang, Irving Harris, Meredith G. Alonso, Jordi Andrade, Laura Helena Bruffaerts, Ronny Cardoso, Graça Chardoul, Stephanie de Girolamo, Giovanni Florescu, Silvia Gureje, Oye Haro, Josep Maria Karam, Aimee Nasser Karam, Elie G. Kovess-Masfety, Viviane Lee, Sing Medina-Mora, Maria Elena Navarro-Mateu, Fernando Posada-Villa, José Stagnaro, Juan Carlos ten Have, Margreet Sampson, Nancy A. Kessler, Ronald C. Vigo, Daniel V. Aguilar-Gaxiola, Sergio Al-Hamzawi, Ali Altwaijri, Yasmin A. Atwoli, Lukoye Benjet, Corina Borges, Guilherme Bromet, Evelyn J. Bunting, Brendan Caldas-de-Almeida, Jose Miguel Chatterji, Somnath Cia, Alfredo H. Degenhardt, Louisa Demyttenaere, Koen Hinkov, Hristo Hu, Chi yi de Jonge, Peter Karam, Georges Kawakami, Norito Kiejna, Andrzej Lepine, Jean Pierre McGrath, John J. Moskalewicz, Jacek Piazza, Marina |
author_role |
author |
author2 |
Kazdin, Alan E. Munthali, Richard J. Hwang, Irving Harris, Meredith G. Alonso, Jordi Andrade, Laura Helena Bruffaerts, Ronny Cardoso, Graça Chardoul, Stephanie de Girolamo, Giovanni Florescu, Silvia Gureje, Oye Haro, Josep Maria Karam, Aimee Nasser Karam, Elie G. Kovess-Masfety, Viviane Lee, Sing Medina-Mora, Maria Elena Navarro-Mateu, Fernando Posada-Villa, José Stagnaro, Juan Carlos ten Have, Margreet Sampson, Nancy A. Kessler, Ronald C. Vigo, Daniel V. Aguilar-Gaxiola, Sergio Al-Hamzawi, Ali Altwaijri, Yasmin A. Atwoli, Lukoye Benjet, Corina Borges, Guilherme Bromet, Evelyn J. Bunting, Brendan Caldas-de-Almeida, Jose Miguel Chatterji, Somnath Cia, Alfredo H. Degenhardt, Louisa Demyttenaere, Koen Hinkov, Hristo Hu, Chi yi de Jonge, Peter Karam, Georges Kawakami, Norito Kiejna, Andrzej Lepine, Jean Pierre McGrath, John J. Moskalewicz, Jacek Piazza, Marina |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) Comprehensive Health Research Centre (CHRC) - pólo NMS RUN |
dc.contributor.author.fl_str_mv |
Stein, Dan J. Kazdin, Alan E. Munthali, Richard J. Hwang, Irving Harris, Meredith G. Alonso, Jordi Andrade, Laura Helena Bruffaerts, Ronny Cardoso, Graça Chardoul, Stephanie de Girolamo, Giovanni Florescu, Silvia Gureje, Oye Haro, Josep Maria Karam, Aimee Nasser Karam, Elie G. Kovess-Masfety, Viviane Lee, Sing Medina-Mora, Maria Elena Navarro-Mateu, Fernando Posada-Villa, José Stagnaro, Juan Carlos ten Have, Margreet Sampson, Nancy A. Kessler, Ronald C. Vigo, Daniel V. Aguilar-Gaxiola, Sergio Al-Hamzawi, Ali Altwaijri, Yasmin A. Atwoli, Lukoye Benjet, Corina Borges, Guilherme Bromet, Evelyn J. Bunting, Brendan Caldas-de-Almeida, Jose Miguel Chatterji, Somnath Cia, Alfredo H. Degenhardt, Louisa Demyttenaere, Koen Hinkov, Hristo Hu, Chi yi de Jonge, Peter Karam, Aimee Nasser Karam, Georges Kawakami, Norito Kiejna, Andrzej Lepine, Jean Pierre McGrath, John J. Moskalewicz, Jacek Piazza, Marina |
dc.subject.por.fl_str_mv |
Contact coverage Effective treatment coverage Insurance Posttraumatic stress disorder Psychiatry and Mental health SDG 3 - Good Health and Well-being |
topic |
Contact coverage Effective treatment coverage Insurance Posttraumatic stress disorder Psychiatry and Mental health SDG 3 - Good Health and Well-being |
description |
Funding Information: The Argentina survey − Estudio Argentino de Epidemiología en Salud Mental (EASM) − was supported by a grant from the Argentinian Ministry of Health (Ministerio de Salud de la Nación) − (Grant Number 2002–17270/13–5). The São Paulo Megacity Mental Health Survey is supported by the State of São Paulo Research Foundation (FAPESP) Thematic Project Grant 03/00204–3. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The Mental Health Study Medellín – Colombia was carried out and supported jointly by the Center for Excellence on Research in Mental Health (CES University) and the Secretary of Health of Medellín. The ESEMeD project is funded by the European Commission (Contracts QLG5–1999-01042; SANCO 2004123, and EAHC 20081308), the Piedmont Region (Italy)), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000–158-CE), Generalitat de Catalunya (2017 SGR 452; 2014 SGR 748), Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The Lebanese Evaluation of the Burden of Ailments and Needs of the Nation (L.E.B.A.N.O.N.) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health / Fogarty International Center (R03 TW006481–01), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from, Algorithm, AstraZeneca, Benta, Bella Pharma, Eli Lilly, Glaxo Smith Kline, Lundbeck, Novartis, OmniPharma, Pfizer, Phenicia, Servier, UPO. The Mexican National Comorbidity Survey (MNCS) is supported by The National Institute of Psychiatry Ramon de la Fuente (INPRFMDIES 4280) and by the National Council on Science and Technology (CONACyT-G30544- H), with supplemental support from the Pan American Health Organization (PAHO). The Nigerian Survey of Mental Health and Wellbeing (NSMHW) is supported by the WHO (Geneva), the WHO (Nigeria), and the Federal Ministry of Health, Abuja, Nigeria. The Portuguese Mental Health Study was carried out by the Department of Mental Health, Faculty of Medical Sciences, NOVA University of Lisbon, with collaboration of the Portuguese Catholic University, and was funded by Champalimaud Foundation, Gulbenkian Foundation, Foundation for Science and Technology (FCT) and Ministry of Health. The Romania WMH study projects “Policies in Mental Health Area” and “National Study regarding Mental Health and Services Use” were carried out by National School of Public Health & Health Services Management (former National Institute for Research & Development in Health), with technical support of Metro Media Transilvania, the National Institute of Statistics-National Centre for Training in Statistics, SC Cheyenne Services SRL, Statistics Netherlands and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL. The Psychiatric Enquiry to General Population in Southeast Spain – Murcia (PEGASUS-Murcia) Project has been financed by the Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejería de Sanidad y Política Social) and Fundación para la Formación e Investigación Sanitarias (FFIS) of Murcia. The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; Grant 044708), and the John W. Alden Trust. Dr. Stein is supported by the Medical Research Council of South Africa (MRC). Publisher Copyright: © 2023, The Author(s). |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-04-27T22:19:12Z 2023-04 2023-04-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/152215 |
url |
http://hdl.handle.net/10362/152215 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1471-244X PURE: 59473424 https://doi.org/10.1186/s12888-023-04605-2 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
mluisa.alvim@gmail.com |
_version_ |
1817545930527735808 |